Amlodipine and Benazepril |
Lotrel |
Clinical Trial: A 6-Week Multi-Center, Randomized, Double-Blind, Parallel Group Study Comparing the Efficacy of Amlodipine Besylate/Benazepril Versus Amlodipine in the Treatment of Severe Hypertension
This study has been completed.
|
Purpose
This trial is designed to study the efficacy of a amlodipine besylate/benazepril treatment regimen versus an amlodipine treatment regimen in the treatment of severe hypertension.
| Condition | Intervention | Phase |
|---|---|---|
| Hypertension | Drug: amlodipine besylate/benazepril hydrochloride | Phase IV |
MedlinePlus related topics: High Blood Pressure
Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Active Control, Parallel Assignment, Safety/Efficacy Study
Further Study Details:
Study start: December 2004
Eligibility
Ages Eligible for Study: 18 Years - 80 Years, Genders Eligible for Study: Both
Criteria
Inclusion Criteria
- Diagnosis of severe hypertension
Exclusion Criteria
- Diastolic blood pressure (DBP) < 60 mm Hg
- Serum potassium < 3.5 or >5.5 mEq/L in the absence of all potassium supplements
- Refractory hypertension defined as SBP ≥ 180 mmHg and/or DBP ≥ 110 mmHg and unresponsive to triple-drug regimens
Other protocol-defined exclusion criteria may apply.
Location Information
New Jersey
Novartis Pharmaceuticals, East Hanover, New Jersey, 07936, United States
More Information
Study ID Numbers: CCIB002FUS19
Last Updated: August 26, 2005
Record first received: August 26, 2005
ClinicalTrials.gov Identifier: NCT00136851
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-08-30
Last Updated: August 26, 2005
Record first received: August 26, 2005
ClinicalTrials.gov Identifier: NCT00136851
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-08-30
Resources
- Amlodipine and Benazepril (Drug Digest)
- Lotrel (Drug Digest)

Not Signed In -

